Organic electroluminescent materials and devices
US-10230060-B2 · Mar 12, 2019 · US
US11183642B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11183642-B2 |
| Application number | US-201715825297-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 29, 2017 |
| Priority date | Oct 3, 2016 |
| Publication date | Nov 23, 2021 |
| Grant date | Nov 23, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Novel phosphorescent metal complexes containing ligands having the Formula I: bearing either a naphthalene or other fused heterocycle moieties such as benzofuran and benzothiophene useful as emitters in OLEDs and improve the device efficiency and the FWHM of the emission are disclosed.
Opening claim text (preview).
We claim: 1. A compound comprising a ligand L A of Formula I: wherein Ring B represents a five- or six-membered aromatic ring; wherein R 3 represents from none to the maximum number of substitutions; wherein X 1 , X 2 , X 3 , and X 4 are each independently a CR or N; wherein at least one of X 1 , X 2 , X 3 , or X 4 is N; wherein at least two adjacent ones of X 1 , X 2 , X 3 , and X 4 are CR and the Rs are fused into a five- or six-membered aromatic ring; wherein (a) R 1 is CR 15 R 16 R 17 or joins with R 2 to form into a ring; or (b) at least two adjacent ones of X 1 , X 2 , X 3 , and X 4 are CR and are fused into a furan ring or a thiophene ring, or (c) both (a) and (b) are true; wherein R, R 1 , R 2 , and R 3 are each independently selected from the group consisting of hydrogen, deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof; wherein R 15 , R 16 , and R 17 are each independently selected from the group consisting of alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, partially or fully deuterated variants thereof, partially or fully fluorinated variants thereof, and combinations thereof; wherein any two substituents among R, R 1 , R 2 , and R 3 are optionally joined to form into an aromatic ring; wherein any two substituents among R 15 , R 16 , and R 17 are optionally joined to form into a ring; wherein L A is coordinated to a metal M at the positions indicated with dashed lines; wherein L A is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and wherein M is optionally coordinated to other ligands. 2. The compound of claim 1 , wherein M is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Au, and Cu. 3. The compound of claim 1 , wherein M is Ir or Pt. 4. The compound of claim 1 , wherein R 1 is tert-butyl, partially or fully deuterated t-butyl, partially or fully fluorinated t-butyl, or a combination of partially deuterated and partially fluorinated t-butyl. 5. The compound of claim 1 , wherein R 1 and R 2 form into an aromatic ring, which can be further substituted. 6. The compound of claim 1 , wherein at least two adjacent ones of X 1 , X 2 , X 3 , and X 4 are CR and are fused into a furan ring or a thiophene ring, and R 2 is selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, and combination thereof. 7. The compound of claim 1 , wherein the compound has formula (L A ) n Ir(L B ) 3-n ; wherein L B is a bidentate ligand; and n is 1, 2, or 3. 8. The compound of claim 7 , wherein L B is selected from the group consisting of: 9. The compound of claim 1 , wherein the ligand L A is selected from the group consisting of: L A391 through L A520 that are based on a structure of Formula III, in which R 1 , R 9 , R 10 , and Y are defined as provided below: Ligand R 1 R 9 R 10 Y L A391 R B6 H H N L A392 R B6 R B1 H N L A393 R B6 R B3 H N L A394 R B6 R B4 H N L A395 R B6 R B7 H N L A396 R B6 R B10 H N L A397 R B6 R A3 H N L A398 R B6 R A34 H N L A399 R B6 H R B1 N L A400 R B6 H R B2 N L A401 R B6 H R B3 N L A402 R B6 H R B4 N L A403 R B6 H R B7 N L A404 R B6 H R B10 N L A405 R B6 H R A3 N L A406 R B6 H R A34 N L A407 R B6 R B1 R B1 N L A408 R B6 R B3 R B3 N L A409 R B6 R B4 R B4 N L A410 R B6 R B7 R B7 N L A411 R B6 R B10 R B10 N L A412 R B6 R A3
Ring systems of four or more rings · CPC title
to three ring carbon atoms · CPC title
Carbazoles; Hydrogenated carbazoles · CPC title
comprising a heterocyclic ring · CPC title
Dibenzothiophenes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.